The safety issue of Pfizer's arthritis treatment Celebrex arose
The safety issue of Pfizer's arthritis treatment Celebrex (ingredient Celecoxib) arose. Ministry of Food and Drug Safety warned that patients treated with COX-2 inhibitor Celebrex should use the lowest effective dose for the shortest possible period of time in order to minimize the potential risk...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
